Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 2/20 | 0.38 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.36 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.36 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.36 |
| ▸ | RNASEL | Q05823 | 2/20 | 0.35 |
| ▸ | NT5E | P21589 | 1/20 | 0.35 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.35 |
| ▸ | FHIT | P49789 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23641743 | 0.92 | TAS1R3 (0.40) | P2RX3P2RX2TAS1R3TAS1R1ADORA1 | |
| SCHEMBL23641845 | 0.85 | P2RX3 (0.44) | P2RX3RNASEL | |
| SCHEMBL23641838 | 0.83 | RNASEL (0.41) | ADORA1RNASEL | |
| SCHEMBL23641810 | 0.82 | RNASEL (0.41) | RNASEL | |
| SCHEMBL24191549 | 0.79 | RNASEL (0.34) | RNASEL | |
| SCHEMBL23641783 | 0.78 | P2RY1 (0.33) | TAS1R3TAS1R1NT5EP2RY1 | |
| SCHEMBL23641857 | 0.78 | RNASEL (0.39) | RNASELNT5E | |
| SCHEMBL23641858 | 0.77 | AURKA (0.31) | TAS1R3TAS1R1NT5E | |
| SCHEMBL24191193 | 0.77 | RNASEL (0.52) | RNASEL | |
| SCHEMBL23641683 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3848054-A1 | NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF | Daiichi Sankyo Company, Limited (JP) | 2021-07-14 | — | — | EP | disclosed |